- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Rifaximin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rifaximin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Rifaximin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rifaximin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
200 mg Tablets
550 mg Tablets
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Rifaximin market are listed below:
Salix Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Rifaximin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rifaximin, with price, sales, revenue and global market share of Rifaximin in 2018 and 2019.
Chapter 3, the Rifaximin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rifaximin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Rifaximin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Rifaximin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Rifaximin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rifaximin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 200 mg Tablets
1.2.3 550 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Rifaximin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Rifaximin Market Size & Forecast
1.4.1 Global Rifaximin Sales in Value (2016-2026))
1.4.2 Global Rifaximin Sales in Volume (2016-2026)
1.4.3 Global Rifaximin Price by Type (2016-2026) & (USD/Unit)
1.5 Global Rifaximin Production Capacity Analysis
1.5.1 Global Rifaximin Total Production Capacity (2016-2026)
1.5.2 Global Rifaximin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rifaximin Market Drivers
1.6.2 Rifaximin Market Restraints
1.6.3 Rifaximin Trends Analysis
2 Manufacturers Profiles
2.1 Salix Pharmaceuticals
2.1.1 Salix Pharmaceuticals Details
2.1.2 Salix Pharmaceuticals Major Business
2.1.3 Salix Pharmaceuticals Rifaximin Product and Services
2.1.4 Salix Pharmaceuticals Rifaximin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Rifaximin Sales by Manufacturer
3.1 Global Rifaximin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Rifaximin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Rifaximin
3.4 Market Concentration Rate
3.4.1 Top 3 Rifaximin Manufacturer Market Share
3.4.2 Top 6 Rifaximin Manufacturer Market Share
3.5 Global Rifaximin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Rifaximin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rifaximin Market Size by Region
4.1.1 Global Rifaximin Sales in Volume by Region (2016-2026)
4.1.2 Global Rifaximin Revenue by Region (2016-2026)
4.2 North America Rifaximin Revenue (2016-2026)
4.3 Europe Rifaximin Revenue (2016-2026)
4.4 Asia-Pacific Rifaximin Revenue (2016-2026)
4.5 South America Rifaximin Revenue (2016-2026)
4.6 Middle East and Africa Rifaximin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Rifaximin Sales in Volume by Type (2016-2026)
5.2 Global Rifaximin Revenue by Type (2016-2026)
5.3 Global Rifaximin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Rifaximin Sales in Volume by Application (2016-2026)
6.2 Global Rifaximin Revenue by Application (2016-2026)
6.3 Global Rifaximin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Rifaximin Sales by Type (2016-2026)
7.2 North America Rifaximin Sales by Application (2016-2026)
7.3 North America Rifaximin Market Size by Country
7.3.1 North America Rifaximin Sales in Volume by Country (2016-2026)
7.3.2 North America Rifaximin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Rifaximin Sales by Type (2016-2026)
8.2 Europe Rifaximin Sales by Application (2016-2026)
8.3 Europe Rifaximin Market Size by Country
8.3.1 Europe Rifaximin Sales in Volume by Country (2016-2026)
8.3.2 Europe Rifaximin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Rifaximin Sales by Type (2016-2026)
9.2 Asia-Pacific Rifaximin Sales by Application (2016-2026)
9.3 Asia-Pacific Rifaximin Market Size by Region
9.3.1 Asia-Pacific Rifaximin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Rifaximin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Rifaximin Sales by Type (2016-2026)
10.2 South America Rifaximin Sales by Application (2016-2026)
10.3 South America Rifaximin Market Size by Country
10.3.1 South America Rifaximin Sales in Volume by Country (2016-2026)
10.3.2 South America Rifaximin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rifaximin Sales by Type (2016-2026)
11.2 Middle East & Africa Rifaximin Sales by Application (2016-2026)
11.3 Middle East & Africa Rifaximin Market Size by Country
11.3.1 Middle East & Africa Rifaximin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Rifaximin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Rifaximin Typical Distributors
12.3 Rifaximin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Rifaximin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Rifaximin Revenue by Application, (USD Million), 2021-2026
Table 3. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Salix Pharmaceuticals Major Business
Table 5. Salix Pharmaceuticals Rifaximin Product and Services
Table 6. Salix Pharmaceuticals Rifaximin Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Rifaximin Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Rifaximin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Rifaximin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Rifaximin Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Rifaximin Production Site of Key Manufacturer
Table 12. Rifaximin New Entrant and Capacity Expansion Plans
Table 13. Rifaximin Mergers & Acquisitions in the Past Five Years
Table 14. Global Rifaximin Sales by Region (2016-2021e) & (K Units)
Table 15. Global Rifaximin Sales by Region (2021-2026) & (K Units)
Table 16. Global Rifaximin Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Rifaximin Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 19. Global Rifaximin Sales by Type (2021-2026) & (K Units)
Table 20. Global Rifaximin Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Rifaximin Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Rifaximin Price by Type (2016-2021e) & (USD/Unit)
Table 23. Global Rifaximin Price by Type (2021-2026) & (USD/Unit)
Table 24. Global Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 25. Global Rifaximin Sales by Application (2021-2026) & (K Units)
Table 26. Global Rifaximin Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Rifaximin Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Rifaximin Price by Application (2016-2021e) & (USD/Unit)
Table 29. Global Rifaximin Price by Application (2021-2026) & (USD/Unit)
Table 30. North America Rifaximin Sales by Country (2016-2021e) & (K Units)
Table 31. North America Rifaximin Sales by Country (2021-2026) & (K Units)
Table 32. North America Rifaximin Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Rifaximin Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 35. North America Rifaximin Sales by Type (2021-2026) & (K Units)
Table 36. North America Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 37. North America Rifaximin Sales by Application (2021-2026) & (K Units)
Table 38. Europe Rifaximin Sales by Country (2016-2021e) & (K Units)
Table 39. Europe Rifaximin Sales by Country (2021-2026) & (K Units)
Table 40. Europe Rifaximin Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Rifaximin Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 43. Europe Rifaximin Sales by Type (2021-2026) & (K Units)
Table 44. Europe Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 45. Europe Rifaximin Sales by Application (2021-2026) & (K Units)
Table 46. Asia-Pacific Rifaximin Sales by Region (2016-2021e) & (K Units)
Table 47. Asia-Pacific Rifaximin Sales by Region (2021-2026) & (K Units)
Table 48. Asia-Pacific Rifaximin Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Rifaximin Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 51. Asia-Pacific Rifaximin Sales by Type (2021-2026) & (K Units)
Table 52. Asia-Pacific Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 53. Asia-Pacific Rifaximin Sales by Application (2021-2026) & (K Units)
Table 54. South America Rifaximin Sales by Country (2016-2021e) & (K Units)
Table 55. South America Rifaximin Sales by Country (2021-2026) & (K Units)
Table 56. South America Rifaximin Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Rifaximin Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 59. South America Rifaximin Sales by Type (2021-2026) & (K Units)
Table 60. South America Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 61. South America Rifaximin Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Rifaximin Sales by Country (2016-2021e) & (K Units)
Table 63. Middle East & Africa Rifaximin Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Rifaximin Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Rifaximin Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Rifaximin Sales by Type (2016-2021e) & (K Units)
Table 67. Middle East & Africa Rifaximin Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Rifaximin Sales by Application (2016-2021e) & (K Units)
Table 69. Middle East & Africa Rifaximin Sales by Application (2021-2026) & (K Units)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Rifaximin Typical Distributors
Table 73. Rifaximin Typical Customers
List of Figures
Figure 1. Rifaximin Picture
Figure 2. Global Rifaximin Sales Market Share by Type in 2020
Figure 3. 200 mg Tablets
Figure 4. 550 mg Tablets
Figure 5. Global Rifaximin Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drug store
Figure 8. Global Rifaximin Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Rifaximin Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Rifaximin Sales (2016-2026) & (K Units)
Figure 11. Global Rifaximin Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Rifaximin Production Capacity (2016-2026) & (K Units)
Figure 13. Global Rifaximin Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Rifaximin Market Drivers
Figure 15. Rifaximin Market Restraints
Figure 16. Rifaximin Market Trends
Figure 17. Global Rifaximin Sales Market Share by Manufacturer in 2020
Figure 18. Global Rifaximin Revenue Market Share by Manufacturer in 2020
Figure 19. Rifaximin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Rifaximin Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Rifaximin Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Rifaximin Sales Market Share by Region (2016-2026)
Figure 23. Global Rifaximin Revenue Market Share by Region (2016-2026)
Figure 24. North America Rifaximin Revenue (2016-2026) & (USD Million)
Figure 25. Europe Rifaximin Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Rifaximin Revenue (2016-2026) & (USD Million)
Figure 27. South America Rifaximin Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Rifaximin Revenue (2016-2026) & (USD Million)
Figure 29. Global Rifaximin Sales Market Share by Type (2016-2026)
Figure 30. Global Rifaximin Revenue Market Share by Type (2016-2026)
Figure 31. Global Rifaximin Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Rifaximin Sales Market Share by Application (2016-2026)
Figure 33. Global Rifaximin Revenue Market Share by Application (2016-2026)
Figure 34. Global Rifaximin Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Rifaximin Sales Market Share by Type (2016-2026)
Figure 36. North America Rifaximin Sales Market Share by Application (2016-2026)
Figure 37. North America Rifaximin Sales Market Share by Country (2016-2026)
Figure 38. North America Rifaximin Revenue Market Share by Country (2016-2026)
Figure 39. United States Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Rifaximin Sales Market Share by Type (2016-2026)
Figure 43. Europe Rifaximin Sales Market Share by Application (2016-2026)
Figure 44. Europe Rifaximin Sales Market Share by Country (2016-2026)
Figure 45. Europe Rifaximin Revenue Market Share by Country (2016-2026)
Figure 46. Germany Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Rifaximin Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Rifaximin Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Rifaximin Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Rifaximin Revenue Market Share by Region (2016-2026)
Figure 55. China Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Rifaximin Sales Market Share by Type (2016-2026)
Figure 62. South America Rifaximin Sales Market Share by Application (2016-2026)
Figure 63. South America Rifaximin Sales Market Share by Country (2016-2026)
Figure 64. South America Rifaximin Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Rifaximin Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Rifaximin Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Rifaximin Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Rifaximin Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Rifaximin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
